Lineage Cell Therapeutics
LCTX
LCTX
106 hedge funds and large institutions have $130M invested in Lineage Cell Therapeutics in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 11 closing their positions.
Holders
106
Holders Change
-1
Holders Change %
-0.93%
% of All Funds
2.43%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
30
Reduced
23
Closed
11
Calls
$215K
Puts
$78K
Net Calls
+$137K
Net Calls Change
+$192K